Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06933004Recruiting
Long-term follow-up after lumbar spine surgery
This study will follow patients who have surgery for lower back problems. It aims to learn about their long-term recovery and outcomes.
TaipeiAges 20–80 - NCT06930820Recruiting
Registry of severe trauma patients
This trial is a registry that collects information about all patients who come to the Emergency Department with a serious injury. It helps doctors learn more about how to treat and improve care for people with severe trauma.
Pavia, PaviaAges 18 years+ - NCT06570447RecruitingPhase 2
Glofitamab and chidamide for relapsed or refractory DLBCL
This trial tests a combination of two drugs, glofitamab and chidamide, for people with diffuse large B-cell lymphoma (DLBCL) that has come back or not responded after at least two prior treatments. The goal is to see if this combination can help when other options have stopped working.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06908434RecruitingPhase 1
GenSci128 for solid tumors with TP53 Y220C mutation
This trial tests a new drug, GenSci128, for people whose solid tumors have a specific TP53 Y220C mutation. The drug aims to reactivate the p53 protein to fight cancer. It is for patients who have exhausted standard treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07269249Recruiting
Dostarlimab before surgery for advanced rectal cancer
This study looks at how well the immunotherapy drug dostarlimab works before surgery in patients with a specific type of advanced rectal cancer that has DNA repair problems (called dMMR/MSI-H). The goal is to see if it is safe and effective in the real world.
NaplesAges 18 years+ - NCT07061223Enrolling by invitation
Comparing two nerve block methods for hip replacement surgery
This trial tests two types of nerve blocks (SFIB and PENG) to find which provides better anesthesia during total hip replacement. It may help you understand which pain control approach could work best for your surgery.
MoscowAges 50–75 - NCT06141798Recruiting
Dialysis Frequency for Older Adults
This trial compares two versus three times weekly dialysis for people aged 60 or older who are just starting maintenance hemodialysis. It aims to find the best schedule for older adults with end stage kidney disease.
Bucheon-siAges 60 years+ - NCT07265882Recruiting
Bedside test for breathing tube patients
This trial uses a simple bedside test to evaluate patients who are on a breathing machine and not breathing on their own. It may help doctors better understand and manage acute respiratory failure.
Pavia, PaviaAges 18–90 - NCT06514651RecruitingPhase 1
MAQ-001 for advanced solid tumors after PD-1/PD-L1 therapy
This study tests a new experimental drug called MAQ-001 in people with advanced solid tumors or lymphomas that have already been treated with a PD-1/PD-L1 checkpoint inhibitor. The goal is to see if MAQ-001 can shrink or control the cancer when other treatments are no longer working.
LyonAges 18 years+ - NCT06903182Recruiting
Timing of TAP block for gallbladder surgery
This study compares giving a nerve block (TAP block) before or after gallbladder removal surgery to see which reduces pain better and improves recovery.
Padua, ItalyAges 18 years+ - NCT03926403Recruiting
Hypnosis support for anxiety during face surgery
This trial looks at whether guided hypnosis can improve how people feel about having face surgery performed with numbing medicine (local anesthesia). If you’re experiencing significant anxiety beforehand, hypnosis support may help you feel more comfortable during your outpatient procedure.
AmiensAges 18 years+ - NCT04357600Enrolling by invitationPhase 1/Phase 2
Stem cell treatment for hepatitis B–related cirrhosis
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Jakarta, DKI JakartaAges 18–65 - NCT07265180Recruiting
Oxytocin and group therapy for schizophrenia
This trial tests whether adding oxytocin (a hormone that helps with social bonding) to group therapy can improve symptoms and social functioning in people with schizophrenia. It compares two different doses of oxytocin to see which works better.
Berlin, State of BerlinAges 18–75 - NCT07262515Recruiting
Blood tests and genes for alcoholic hepatitis recovery
This study looks at blood samples and genetic information from people with acute alcoholic hepatitis to understand why some recover better than others. It aims to find better ways to predict and improve outcomes.
ParisAges 18 years+ - NCT06709976Enrolling by invitation
Fertility test and IVF study
This study looks at whether a special test called ReceptIVFity, which checks the health of the vagina, can help improve pregnancy rates in women undergoing IVF or ICSI. If you are planning IVF or ICSI and are of European origin, you might be able to join.
Rotterdam, South HollandAges 18–42 - NCT06925776Recruiting
Community health workers for kidney disease patients
This trial tests whether a community health worker can help patients with advanced kidney disease get better care and education about home dialysis. The goal is to improve patient involvement and make it easier to navigate social needs.
The Bronx, New YorkAges 18 years+ - NCT06516822Recruiting
Comparing two ablation methods for long-standing atrial fibrillation
This study tests whether adding extra scar lines (linear ablation) to the standard pulmonary vein isolation (CPVI) is better than CPVI alone for people with long-standing persistent AF that has lasted 1 to 3 years. The goal is to see which approach reduces AF better.
Beijing, Beijing MunicipalityAges 18–75 - NCT07260708RecruitingPhase 1
Testing TQB2922 injection for advanced lung cancer
This trial tests a new injection called TQB2922 for people with advanced non-squamous non-small cell lung cancer who have already tried standard treatments. The goal is to see if the drug can help shrink tumors or slow the cancer's growth.
Guangzhou, GuangdongAges 18–75 - NCT07258589Recruiting
Taste training for people on targeted cancer pills
This study tests a taste-training program for people who notice changes in their sense of taste while taking targeted cancer pills (tyrosine kinase inhibitors). The goal is to help improve your eating experience and nutrition during treatment.
AmsterdamAges 18–70 - NCT07258537Enrolling by invitation
Comparing two hand therapies for sacroiliac joint pain
This study compares two types of hands-on therapy (a gentle side-lying adjustment vs. a lower back roll) to see which works better for long-lasting low back pain caused by the sacroiliac joint. If you have ongoing pain and are open to physical treatments, this trial may help find the best approach.
Gujrat, Punjab ProvinceAges Any age - NCT06518265Recruiting
Locked nail surgery for high-risk ankle fractures
This study looks at how well a special locking nail works for ankle fractures in patients with skin problems or injuries that make standard surgery risky. It aims to find out who benefits most from this less invasive method.
La TroncheAges 18–100 - NCT05053802RecruitingPhase 2
Microwave tumor ablation plus immunotherapy for multiple lung cancers
This Phase 2 trial studies whether combining microwave ablation (a procedure to destroy lung tumors) with an immune checkpoint inhibitor can control multiple early lung cancers safely. It also aims to see how well the immune treatment helps after ablation, in people whose cancers have not spread.
Shanghai, Shanghai MunicipalityAges 18–79 - NCT07256782RecruitingPhase 1/Phase 2
A study of QLC5508 combinations for advanced solid tumors
This trial tests a new drug called QLC5508, given in combination with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy or who haven't had treatment yet. The goal is to see if the combination can shrink tumors or slow their growth.
ShanghaiAges 18 years+ - NCT06823401Recruiting
Checking body response to lung cancer immunotherapy
This study looks at how your body reacts to checkpoint inhibitors (immunotherapy drugs like Keytruda or Opdivo) for NSCLC. It involves blood tests to check for antibodies your immune system might make against the drug.
Roma, RMAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.